期刊文献+

乳腺癌患者外周血清中APC基因启动子甲基化异常的检测及其意义 被引量:8

Detection and Significance of APC Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
下载PDF
导出
摘要 背景与目的:检测肿瘤患者外周血中肿瘤相关标志物是当前肿瘤研究的热点之一,恶性肿瘤患者外周血中存在游离的肿瘤相关DNA已引起肿瘤学界的极大关注,人们曾在多种肿瘤患者血清中发现与原发肿瘤相同的DNA变异。本研究以APC(adenomatouspolyposiscoli)基因启动子甲基化作为肿瘤标志物,探讨乳腺癌患者外周血清中游离的肿瘤相关DNA与肿瘤组织及临床病理参数的相关性。方法:采用甲基化特异性PCR(methylationspecific-PCR,MSP)方法分别检测84例乳腺癌组织、癌旁正常腺体组织及外周血清中游离DNAAPC基因启动子甲基化状况。结果:84例乳腺癌组织APC基因启动子甲基化频率为45.2%(38/84),相应外周血清中同样DNA变异阳性检出率为31.0%(26/84)。外周血清中DNA甲基化变异与肿瘤组织的甲基化状况显著相关(r=0.977,P0.002)。检测外周血清中APC基因甲基化的敏感性为68.4%,特异性为97.8%肿瘤组织及外周血清中游离DNA甲基化异常与临床分期、病理类型、肿块大小及受体状况无相关性(P>0.05)。肿瘤组织未检测到甲基化患者的血清中及健康人血清中均未检测到该基因甲基化变异。结论:乳腺癌患者外周血清中肿瘤相关DNA甲基化与肿瘤组织中相同基因的变异显著相关。 BACKGROUND & OBJECTIVE: Detection of circulating tumor markers is one of current hot spots in tumor research. Free tumor DNA may exist in the peripheral blood of malignant tumor patients. Identical DNA mutations existing in both peripheral serum and primary tumor are found in many kinds of malignant tumors. This study used adenomatous polyposis coli (APC) gene promoter hypermethylation as a tumor marker to investigate the correlations of free tumor DNA to primary tumor and clinicopathologic features of breast cancer. METHODS: The methylation status of APC gene in tumor tissue, paracancer normal tissue, and paired peripheral serum from 84 patients with breast cancer and 10 patients with benign breast diseases were detected by methylation-specific polymerase chain reaction (MSP). RESULTS: The detection rate of APC gene promoter hypermethylation was 45.2% in tumor tissues and 31.0% in paired peripheral sera. APC gene hypermethylation in peripheral serum was significantly correlated to that in tumor tissue (r=0.977, P=0.002), The sensitivity of detecting APC gene hypermethylation in peripheral serum was 68.4%; the specificity was 97.8%. The aberrant methylation of APC gene in tumor tissue and peripheral serum had no correlation to patients' age, tumor stage, tumor size, histological type, and receptor status (P〉0,05). No aberrant methylation of APC gene was found in the serum samples from healthy control and the patients without gene methylation in tumor tissue. CONCLUSION: The aberrant tumor gene methylation in peripheral serum of breast cancer patients is significantly correlated to that in primary tumor.
出处 《癌症》 SCIE CAS CSCD 北大核心 2007年第1期44-47,共4页 Chinese Journal of Cancer
关键词 乳腺肿瘤 血清游离DNA APC基因 甲基化 Breast neoplasm Free DNA in serum APC gene Aberrant methylation
  • 相关文献

参考文献14

  • 1蔡清清,黄慧强,林天歆,姜文奇.乳腺癌患者外周血中循环癌细胞的检测及其临床意义[J].癌症,2005,24(7):837-841. 被引量:18
  • 2Anker P, Mulcahy H, Chen X Q, et al. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients [J]. Cancer Metastasis Rev, 1999,18( 1 ) :65-73.
  • 3Balogh G A, Mailo D A, Corte M M, et al. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer [J]. Int J Oncol, 2006,28(4) :995-1002.
  • 4Fiegl H, Millinger S, Mueller-Holzner E, et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients [J]. Cancer Res, 2005,65(4) : 1141-1145.
  • 5张敬杰,欧阳涛,邓国仁,万文徽,徐光炜.乳腺癌患者血浆中E钙粘素基因启动子甲基化的检测与临床意义[J].中华普通外科杂志,2003,18(11):663-665. 被引量:5
  • 6Herman J G, Graff J R, Myohanen S, et al. Methylationspecific PCR:a novel PCR assay for methylation status of CpG islands [J]. Proc Natl Acad Sci USA, 1996,93(18):9821-9826.
  • 7Virmani A K, Rathi A, Sathyanarayana U G, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas [J]. Clin Cancer Res, 2001,7(7) : 1998-2004.
  • 8Baylin S B, Herman J G. DNA hypermethylation in tumorigenesis [J]. TIG, 2000, 16(4) : 168-173.
  • 9Yamada T, Nakamori S, Ohzato H, et al. Circulating DNA K-ras mutation in pancreatic adenocarcinoma [J]. Clin Cancer Res, 1998,4(6) : 1527-1532.
  • 10Castells A, Puig P, Mora J, et al. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma:diagnostic utility and prognostic significance [J]. J Clin Oncol, 1999,17(2) :578-584.

二级参考文献8

  • 1Carter CL, Allen C, Henson DE. Relation of tumor size,lymph node status, and survival in 24 740 breast cancer cases[J]. Cancer, 1989,63(1):181-187.
  • 2Pantel K, Felber E, Schlimok G. Detection and characterization of residual disease in breast cancer [J]. J Hematother, 1994,3(4) :315-322.
  • 3Mansi JL, Gogas H, Bliss JM, et al. Outcome of primary breast cancer patients with micrometastases: a long-term follow-up study [J]. Lancet, 1999,354(9174): 197-202.
  • 4Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage Ⅰ ,Ⅱ, or Ⅲ breast cancer [J]. N Engl J Med, 2000,342(8):525-533.
  • 5Gebauer G, Fehm T, Merkle E, et al. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up [J]. J Clin Oncol, 2001,19 (16): 3669-3674.
  • 6Kraeft SK, Sutherland R, Gravelin L, et al. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system [J]. Clin Cancer Res, 2000,6(2):434-442.
  • 7Witzig TE, Bossy B, Kimlinger T, et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy [J]. Clin Cancer Res, 2002,8(5): 1085-1091.
  • 8Shoo Peng Siah,Diana M Quinn,Graeme D Bennett,Graeme Casey,Robert LP Flower,Graeme Suthers,Zbigniew Rudzki. Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer[J] 2000,Breast Cancer Research and Treatment(2):135~142

共引文献21

同被引文献73

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部